Terms: = Lymphoma AND MLLT3, AF9, 4300, ENSG00000171843, P42568, YEATS3, AF-9
91 results:
1. CD69 marks a subpopulation of acute myeloid leukemia with enhanced colony forming capacity and a unique signaling activation state.
Antony ML; Chang D; Noble-Orcutt KE; Kay A; Jensen JL; Mohei H; Myers CL; Sachs K; Sachs Z
Leuk Lymphoma; 2023; 64(7):1262-1274. PubMed ID: 37161853
[TBL] [Abstract] [Full Text] [Related]
2. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
[TBL] [Abstract] [Full Text] [Related]
3. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
[TBL] [Abstract] [Full Text] [Related]
4. Lineage switch in a pediatric patient with KMT2A-mllt3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review.
Gao L; Lu J; Li J; Hu Y; Lu Y; Du W; Hu S
Int J Hematol; 2023 May; 117(5):781-785. PubMed ID: 36472792
[TBL] [Abstract] [Full Text] [Related]
5. Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia.
Isobe T; Takagi M; Sato-Otsubo A; Nishimura A; Nagae G; Yamagishi C; Tamura M; Tanaka Y; Asada S; Takeda R; Tsuchiya A; Wang X; Yoshida K; Nannya Y; Ueno H; Akazawa R; Kato I; Mikami T; Watanabe K; Sekiguchi M; Seki M; Kimura S; Hiwatari M; Kato M; Fukuda S; Tatsuno K; Tsutsumi S; Kanai A; Inaba T; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Kotecha RS; Cruickshank MN; Ishikawa F; Morio T; Eguchi M; Deguchi T; Kiyokawa N; Arakawa Y; Koh K; Aoki Y; Ishihara T; Tomizawa D; Miyamura T; Ishii E; Mizutani S; Wilson NK; Göttgens B; Miyano S; Kitamura T; Goyama S; Yokoyama A; Aburatani H; Ogawa S; Takita J
Nat Commun; 2022 Aug; 13(1):4501. PubMed ID: 36042201
[TBL] [Abstract] [Full Text] [Related]
6. Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements.
Wen J; Zhou M; Shen Y; Long Y; Guo Y; Song L; Xiao J
BMC Cancer; 2022 Aug; 22(1):859. PubMed ID: 35933338
[TBL] [Abstract] [Full Text] [Related]
7. PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch.
Nakajima K; Kubota H; Kato I; Isobe K; Ueno H; Kozuki K; Tanaka K; Kawabata N; Mikami T; Tamefusa K; Nishiuchi R; Saida S; Umeda K; Hiramatsu H; Adachi S; Takita J
Cancer Sci; 2022 Jul; 113(7):2472-2476. PubMed ID: 35467057
[TBL] [Abstract] [Full Text] [Related]
8. Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB).
Jurutka PW; di Martino O; Reshi S; Mallick S; Sabir ZL; Staniszewski LJP; Warda A; Maiorella EL; Minasian A; Davidson J; Ibrahim SJ; Raban S; Haddad D; Khamisi M; Suban SL; Dawson BJ; Candia R; Ziller JW; Lee MY; Liu C; Liu W; Marshall PA; Welch JS; Wagner CE
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830251
[TBL] [Abstract] [Full Text] [Related]
9. Mature B cell acute lymphoblastic leukaemia with KMT2A-mllt3 transcripts in children: three case reports and literature reviews.
Cui Y; Zhou M; Zou P; Liao X; Xiao J
Orphanet J Rare Dis; 2021 Jul; 16(1):331. PubMed ID: 34330316
[TBL] [Abstract] [Full Text] [Related]
10. Is acute lymphoblastic leukemia with mature B-cell phenotype and
Hidalgo-Gómez G; Palacio-Garcia C; Gallur L; Blanco A; Tazón-Vega B; Saumell S; Martínez N; Murillo L; Murciano T; Velasco P; Bosch F; Diaz-Heredia C; Ortega M
Leuk Lymphoma; 2021 Sep; 62(9):2202-2210. PubMed ID: 33827367
[TBL] [Abstract] [Full Text] [Related]
11. Therapy-induced Deletion in 11q23 Leading to Fusion of
Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
[TBL] [Abstract] [Full Text] [Related]
12. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R
EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509
[TBL] [Abstract] [Full Text] [Related]
13. Preleukemic fusion genes typical for acute myeloid leukemia.
Klimová D; Styk J; Svoboda M; Humplíková S; Repiská V
Vnitr Lek; 2021; 67(E-5):9-12. PubMed ID: 35459386
[TBL] [Abstract] [Full Text] [Related]
14.
Kato S; Kubota Y; Sekiguchi M; Watanabe K; Shinozaki-Ushiku A; Takita J; Hiwatari M
Pediatr Hematol Oncol; 2021 Apr; 38(3):281-289. PubMed ID: 33150819
[No Abstract] [Full Text] [Related]
15. MiR-181a enhances drug sensitivity of mixed lineage leukemia-rearranged acute myeloid leukemia by increasing poly(ADP-ribose) polymerase1 acetylation.
Zhou D; Xu P; Zhou X; Diao Z; Ouyang J; Yan G; Chen B
Leuk Lymphoma; 2021 Jan; 62(1):136-146. PubMed ID: 32996365
[TBL] [Abstract] [Full Text] [Related]
16. First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia.
Tandon S; Shago M; Davidson S; Kanwar N; Fuligni F; Shlien A; Whitlock J; Villani A; Abla O
Cancer Genet; 2020 Oct; 248-249():31-33. PubMed ID: 32992102
[TBL] [Abstract] [Full Text] [Related]
17. Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.
Matsuo H; Yoshida K; Nakatani K; Harata Y; Higashitani M; Ito Y; Kamikubo Y; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Miyano S; Meggendorfer M; Haferlach C; Ogawa S; Adachi S
Blood Adv; 2020 Oct; 4(19):4623-4631. PubMed ID: 32991719
[TBL] [Abstract] [Full Text] [Related]
18. Heritable genetic background alters survival and phenotype of Mll-af9-induced leukemias.
Young K; Loberg MA; Eudy E; Schwartz LS; Mujica KD; Trowbridge JJ
Exp Hematol; 2020 Sep; 89():61-67.e3. PubMed ID: 32768438
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of acute leukemia with attenuated Salmonella typhimurium strain VNP20009.
Li M; Lu M; Lai Y; Zhang X; Li Y; Mao P; Liang Z; Mu Y; Lin Y; Zhao AZ; Zhao Z; Zhou S; Li F
Biomed Pharmacother; 2020 Sep; 129():110425. PubMed ID: 32570123
[TBL] [Abstract] [Full Text] [Related]
20. Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia.
Loftus JP; Yahiaoui A; Brown PA; Niswander LM; Bagashev A; Wang M; Schauf A; Tannheimer S; Tasian SK
Haematologica; 2021 Apr; 106(4):1067-1078. PubMed ID: 32414848
[TBL] [Abstract] [Full Text] [Related]
[Next]
